From Pandemic to Policy: Leveraging COVID-19 Lessons to Strengthen Antimicrobial Stewardship

This is a great example demonstrating how research conducted during the COVID-19 pandemic can inform global antimicrobial resistance (AMR) policy, support antimicrobial stewardship (AMS), and ultimately help save lives. This study assessed AMS practices before and during the pandemic using three integrated methods: a systematic review of 13 global studies, a retrospective analysis of antibiotic use in 640 NHS hospital patients, and a cross-sectional survey of 240 healthcare professionals. Despite bacterial co-infections being confirmed in less than 10% of patients, over 70% received antibiotics, highlighting urgent stewardship challenges. The research was complemented by a review of national and international policies, including guidance from WHO and the UK 5-Year AMR Action Plan. Key findings emphasised the importance of embedding AMS in emergency preparedness, improving diagnostics, and supporting interprofessional collaboration. These insights were translated into a policy brief by the South Centre, offering actionable recommendations for building resilient AMS systems and combating AMR globally.